Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
99.20
-1.30 (-1.29%)
Aug 19, 2026, 9:33 AM CST

Alar Pharmaceuticals Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
32.755.82469.270.8-
Revenue Growth
-57.57%-52.67%-98.76%58559.00%--
Gross Profit
2.592.143.79469.270.8-
Operating Income
-171.25-167.8-67.94385.53-46.53-93.3
Net Income
-72.13-79.6818.17382.62-19.87-64.23
Earnings Per Share
-1.07-1.190.276.71-0.35-1.13
EPS Growth
---95.98%---

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '24 Dec '23 Dec '22
Taiwan
1.5-0.80.8
United State
-5.82--
United Kingdom
1.25-468.47-
Total
2.755.82469.270.8

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,2852,2962,431895.99486.22519.07
Total Debt
1.853.570.61.412.690.95
Net Cash (Debt)
2,2832,2932,430894.58483.53518.12
Net Cash Growth
-2.49%-5.66%171.69%85.01%-6.68%-7.39%
Net Cash Per Share
33.8434.3236.7015.688.489.09

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-186.65-171.03-75.27403.57-32.95-63.47
Capital Expenditures
-2.98-2.87-32.17-6.34-1.14-1.58
Free Cash Flow
-189.63-173.9-107.44397.23-34.09-65.05
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
86.40%77.73%65.15%100.00%100.00%-
Operating Margin
-5708.40%-6095.10%-1168.02%82.15%-5815.88%-
Pretax Margin
-1750.33%-2868.54%636.91%83.34%-4067.25%-
Profit Margin
-2404.27%-2894.41%312.36%81.53%-2483.88%-
FCF Margin
-6320.83%-6316.67%-1846.95%84.65%-4260.75%-

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.1000.1000.2501.500
Dividend Per Share Growth
0%-60.00%-83.33%-
Dividend Yield
0.10%0.03%0.18%0.72%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--520.2131.21--
Forward PE
-223.48246.09---
P/FCF Ratio
---30.06--
PS Ratio
2237.807376.391624.9325.458193.75-